Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 125

1.

Separate and joint effects of marine oil and simvastatin in patients with combined hyperlipidemia.

Davidson MH, Macariola-Coad JR, McDonald AM, Maki KC, Hall HA.

Am J Cardiol. 1997 Sep 15;80(6):797-8.

PMID:
9315596
[PubMed - indexed for MEDLINE]
2.

Effects of simvastatin and ciprofibrate alone and in combination on lipid profile, plasma fibrinogen and low density lipoprotein particle structure and distribution in patients with familial combined hyperlipidaemia and coronary artery disease.

Kontopoulos AG, Athyros VG, Papageorgiou AA, Hatzikonstandinou HA, Mayroudi MC, Boudoulas H.

Coron Artery Dis. 1996 Nov;7(11):843-50.

PMID:
8993943
[PubMed - indexed for MEDLINE]
3.
4.

Safety and efficacy of long-term statin-fibrate combinations in patients with refractory familial combined hyperlipidemia.

Athyros VG, Papageorgiou AA, Hatzikonstandinou HA, Didangelos TP, Carina MV, Kranitsas DF, Kontopoulos AG.

Am J Cardiol. 1997 Sep 1;80(5):608-13.

PMID:
9294990
[PubMed - indexed for MEDLINE]
5.

Randomized crossover study of gemfibrozil versus lovastatin in familial combined hyperlipidemia: additive effects of combination treatment on lipid regulation.

Zambón D, Ros E, Rodriguez-Villar C, Laguna JC, Vázquez M, Sanllehy C, Casals E, Sol JM, Hernández G.

Metabolism. 1999 Jan;48(1):47-54.

PMID:
9920144
[PubMed - indexed for MEDLINE]
6.

Effectiveness and tolerability of simvastatin plus fenofibrate for combined hyperlipidemia (the SAFARI trial).

Grundy SM, Vega GL, Yuan Z, Battisti WP, Brady WE, Palmisano J.

Am J Cardiol. 2005 Feb 15;95(4):462-8. Erratum in: Am J Cardiol. 2006 Aug 1;98(3):427-8.

PMID:
15695129
[PubMed - indexed for MEDLINE]
7.

Efficacy of fenofibrate and simvastatin on endothelial function and inflammatory markers in patients with combined hyperlipidemia: relations with baseline lipid profiles.

Wang TD, Chen WJ, Lin JW, Cheng CC, Chen MF, Lee YT.

Atherosclerosis. 2003 Oct;170(2):315-23.

PMID:
14612213
[PubMed - indexed for MEDLINE]
8.

Comparison of effects of simvastatin alone versus fenofibrate alone versus simvastatin plus fenofibrate on lipoprotein subparticle profiles in diabetic patients with mixed dyslipidemia (from the Diabetes and Combined Lipid Therapy Regimen study).

May HT, Anderson JL, Pearson RR, Jensen JR, Horne BD, Lavasani F, Yannicelli HD, Muhlestein JB.

Am J Cardiol. 2008 Feb 15;101(4):486-9. doi: 10.1016/j.amjcard.2007.09.095. Epub 2007 Dec 26.

PMID:
18312763
[PubMed - indexed for MEDLINE]
9.

Long-term efficacy and safety of fenofibrate and a statin in the treatment of combined hyperlipidemia.

Ellen RL, McPherson R.

Am J Cardiol. 1998 Feb 26;81(4A):60B-65B. Review.

PMID:
9526816
[PubMed - indexed for MEDLINE]
10.

Effects of adding fenofibrate (200 mg/day) to simvastatin (10 mg/day) in patients with combined hyperlipidemia and metabolic syndrome.

Vega GL, Ma PT, Cater NB, Filipchuk N, Meguro S, Garcia-Garcia AB, Grundy SM.

Am J Cardiol. 2003 Apr 15;91(8):956-60.

PMID:
12686335
[PubMed - indexed for MEDLINE]
12.

An omega-3 polyunsaturated fatty acid concentrate administered for one year decreased triglycerides in simvastatin treated patients with coronary heart disease and persisting hypertriglyceridaemia.

Durrington PN, Bhatnagar D, Mackness MI, Morgan J, Julier K, Khan MA, France M.

Heart. 2001 May;85(5):544-8.

PMID:
11303007
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Effects of simvastatin (40 and 80 mg/day) in patients with mixed hyperlipidemia.

Stein E, Plotkin D, Bays H, Davidson M, Dujovne C, Korenman S, Stepanavage M, Mercuri M.

Am J Cardiol. 2000 Aug 15;86(4):406-11.

PMID:
10946033
[PubMed - indexed for MEDLINE]
14.

Safety and efficacy of long-term co-administration of fenofibrate and ezetimibe in patients with mixed hyperlipidemia.

McKenney JM, Farnier M, Lo KW, Bays HE, Perevozkaya I, Carlson G, Davies MJ, Mitchel YB, Gumbiner B.

J Am Coll Cardiol. 2006 Apr 18;47(8):1584-7. Epub 2006 Mar 30.

PMID:
16630994
[PubMed - indexed for MEDLINE]
Free Article
15.

Efficacy and safety of ezetimibe/simvastatin association on non-diabetic and diabetic patients with polygenic hypercholesterolemia or combined hyperlipidemia and previously intolerant to standard statin treatment.

Derosa G, D'Angelo A, Franzetti IG, Ragonesi PD, Gadaleta G, Scalise F, Ciccarelli L, Piccinni MN, Cicero AF.

J Clin Pharm Ther. 2009 Jun;34(3):267-76.

PMID:
19650249
[PubMed - indexed for MEDLINE]
16.

Correlation of non-high-density lipoprotein cholesterol and low-density lipoprotein cholesterol with apolipoprotein B during simvastatin + fenofibrate therapy in patients with combined hyperlipidemia (a subanalysis of the SAFARI trial).

Grundy SM, Vega GL, Tomassini JE, Tershakovec AM.

Am J Cardiol. 2009 Aug 15;104(4):548-53. doi: 10.1016/j.amjcard.2009.04.018.

PMID:
19660610
[PubMed - indexed for MEDLINE]
17.

Lipid-altering efficacy and safety of ezetimibe/simvastatin coadministered with extended-release niacin in patients with type IIa or type IIb hyperlipidemia.

Guyton JR, Brown BG, Fazio S, Polis A, Tomassini JE, Tershakovec AM.

J Am Coll Cardiol. 2008 Apr 22;51(16):1564-72. doi: 10.1016/j.jacc.2008.03.003.

PMID:
18420099
[PubMed - indexed for MEDLINE]
Free Article
18.

Treatment of severe, resistant familial combined hyperlipidemia with a bezafibrate-lovastatin combination.

Yeshurun D, Abukarshin R, Elias N, Lanir A, Naschitz JE.

Clin Ther. 1993 Mar-Apr;15(2):355-63.

PMID:
8519043
[PubMed - indexed for MEDLINE]
19.

Comparison of once-daily, niacin extended-release/lovastatin with standard doses of atorvastatin and simvastatin (the ADvicor Versus Other Cholesterol-Modulating Agents Trial Evaluation [ADVOCATE]).

Bays HE, Dujovne CA, McGovern ME, White TE, Kashyap ML, Hutcheson AG, Crouse JR; ADvicor Versus Other Cholesterol-Modulating Agents Trial Evaluation.

Am J Cardiol. 2003 Mar 15;91(6):667-72.

PMID:
12633795
[PubMed - indexed for MEDLINE]
20.

Effect of combination nicotinic acid and gemfibrozil treatment on intermediate density lipoprotein, and subclasses of low density lipoprotein and high density lipoprotein in patients with combined hyperlipidemia.

Superko HR, Garrett BC, King SB 3rd, Momary KM, Chronos NA, Wood PD.

Am J Cardiol. 2009 Feb 1;103(3):387-92. doi: 10.1016/j.amjcard.2008.09.103. Epub 2008 Nov 27.

PMID:
19166694
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk